earnings
CT
NASDAQ · CTXR
Citius Pharmaceuticals, Inc.
Healthcare · Biotechnology
$0.59
Up+$0.00 (+0.57%)
Updated Sep 11, 2026, 10:08 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.96M
- P/E ratio
- -0.32
- Dividend yield
- 0.00%
- 52-week range
- $0.47 – $2.19
- Volume
- 164.99K
- Avg. volume
- 805.13K
Price performance
CTXR price history
1M range · 20 trading sessions · Daily adjusted prices
CTXR closed at $0.59 after 20 trading sessions, down 20.22% for the selected period.
- Last close
- $0.59
- Period change
- -20.22%
- Period low
- $0.56
- Period high
- $0.76
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $0.60 | $0.6099 | $0.5805 | $0.5853 | 164.99K |
| Sep 9, 2026 | $0.601 | $0.61 | $0.5807 | $0.582 | 76.92K |
| Sep 8, 2026 | $0.581 | $0.6169 | $0.5804 | $0.6005 | 310.57K |
| Sep 4, 2026 | $0.602 | $0.6099 | $0.58 | $0.5877 | 299.63K |
| Sep 3, 2026 | $0.5845 | $0.6143 | $0.5845 | $0.602 | 250.74K |
| Sep 2, 2026 | $0.563 | $0.5899 | $0.563 | $0.5795 | 223.9K |
| Sep 1, 2026 | $0.5799 | $0.5899 | $0.5691 | $0.5691 | 226.56K |
| Aug 31, 2026 | $0.58 | $0.5929 | $0.57 | $0.5802 | 281.13K |
| Aug 28, 2026 | $0.619 | $0.63 | $0.59 | $0.6021 | 361.74K |
| Aug 27, 2026 | $0.577 | $0.65 | $0.577 | $0.629 | 827.78K |
| Aug 26, 2026 | $0.5961 | $0.6099 | $0.5701 | $0.5771 | 442.88K |
| Aug 25, 2026 | $0.5777 | $0.67 | $0.5777 | $0.6037 | 2.16M |
| Aug 24, 2026 | $0.61 | $0.61 | $0.57 | $0.5754 | 392.89K |
| Aug 21, 2026 | $0.605 | $0.6125 | $0.60 | $0.6002 | 160.69K |
| Aug 20, 2026 | $0.6365 | $0.6428 | $0.5711 | $0.5998 | 588.51K |
| Aug 19, 2026 | $0.58 | $0.658 | $0.5626 | $0.6375 | 2.2M |
| Aug 18, 2026 | $0.5579 | $0.5793 | $0.5511 | $0.5718 | 446.3K |
| Aug 17, 2026 | $0.622 | $0.6299 | $0.5486 | $0.562 | 2.43M |
| Aug 14, 2026 | $0.75 | $0.79 | $0.7276 | $0.7556 | 688.96K |
| Aug 13, 2026 | $0.7686 | $0.78 | $0.7106 | $0.7336 | 435.86K |
Latest CTXR news
The latest Smart Investors Daily articles mentioning CTXR.
Stock researchCompany · Forecast
Loading stock research…